These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 631967)

  • 21. Desamino arginine vasopressin (DDAVP) as a diagnostic agent.
    Somerfield SD; Hocken AG
    N Z Med J; 1977 Nov; 86(600):472-3. PubMed ID: 343010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The pathophysiological significance of increased renal kallikrein excretion in Bartter's syndrome (author's transl)].
    Sasaki H; Kawasaki T; Abe K
    Fukuoka Igaku Zasshi; 1978 Jan; 69(1):15-22. PubMed ID: 649033
    [No Abstract]   [Full Text] [Related]  

  • 24. On the pathogenetic role of prostaglandins in Bartter's syndrome.
    Nielsen I; Hesse B; Christensen P
    Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP; Marosi J; Fischer J; Takó J; Kiss N
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bartter's syndrome: variability and clinical course].
    Cabezas R; Bosch F; García A; Ampudia J; Webb SM
    Med Clin (Barc); 1993 Jan; 100(2):63-5. PubMed ID: 8429712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of the immaturity of the ADH-dependent cAMP system in conscious newborn piglets--possible impairing effects of renal prostaglandins.
    Joppich R; Häberle DA; Weber PC
    Pediatr Res; 1981 Mar; 15(3):278-81. PubMed ID: 6261212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction of increased prostacyclin production in Bartter's syndrome by indomethacin.
    Güllner HG; Cerletti C; Bartter FC; Gill JR; Smith JB
    Trans Assoc Am Physicians; 1980; 93():130-40. PubMed ID: 7018063
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of fluid intake on basal and vasopressin-responsive urinary prostaglandin E.
    Campbell HT; Craven PA; DeRubertis FR
    Am J Physiol; 1983 Jul; 245(1):F48-57. PubMed ID: 6869538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free dopamine excretion in disorders with increased prostaglandin synthesis.
    Güllner HG
    Prostaglandins Leukot Med; 1982 Jun; 8(6):545-51. PubMed ID: 6955810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prostaglandin synthetase inhibition on captopril-induced changes in renal function in Bartter's syndrome.
    Rudin A; Granérus G; Aurell M
    Scand J Urol Nephrol Suppl; 1984; 79():59-62. PubMed ID: 6433438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Bartter's syndrome with indomethacin.
    Garin EH; Fennell RS; Iravani A; Richard GA
    Am J Dis Child; 1980 Mar; 134(3):258-61. PubMed ID: 6767392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidiuretic responses to injected desmopressin, alone and with indomethacin.
    Moses AM; Moses LK; Notman DD; Springer J
    J Clin Endocrinol Metab; 1981 May; 52(5):910-3. PubMed ID: 7228994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bartter's syndrome--abnormal prostaglandin production].
    Kono T
    Nihon Rinsho; 1978 May; Suppl():1530-1. PubMed ID: 691414
    [No Abstract]   [Full Text] [Related]  

  • 35. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
    Gill JR; Frölich JC; Bowden RE; Taylor AA; Keiser HR; Seyberth HW; Oates JA; Bartter FC
    Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on kidney function in subjects exposed to organic solvents. II. The effect of desmopressin in a concentration test and the effect of exposure to organic solvents on renal concentrating ability.
    Askergren A; Allgën LG; Bergström J
    Acta Med Scand; 1981; 209(6):485-8. PubMed ID: 7257866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The defect in chloride reabsorption and influence of indomethacin in the renal tubules of Bartter's syndrome (author's transl)].
    Yasuda G; Shionoiri H; Hikuma K; Uneda S; Nagasawa T
    Horumon To Rinsho; 1981 Jul; 29(7):827-30. PubMed ID: 7307299
    [No Abstract]   [Full Text] [Related]  

  • 38. [Increased renal prostaglandin E2 secretion in Bartter's syndrome].
    Schwarz HA; Weidmann P; Messerli FH; Zia PK; Flammer J; Reubi RC
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1870-2. PubMed ID: 929154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandins and Bartter's syndrome.
    Dunn MJ
    Kidney Int; 1981 Jan; 19(1):86-102. PubMed ID: 7012423
    [No Abstract]   [Full Text] [Related]  

  • 40. Bartter's syndrome: physiological and pharmacological studies.
    Delaney VB; Oliver JF; Simms M; Costello J; Bourke E
    Q J Med; 1981; 50(198):213-32. PubMed ID: 6171004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.